Cancer cells exploit an orphan RNA to drive metastatic progression

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Small noncoding RNAs play crucial roles in gene regulation.
• Aberrant expression of noncoding RNAs is implicated in various cancers, including breast cancer.
• The specific roles of certain noncoding RNAs in breast cancer metastasis remain to be fully elucidated.

Purpose of the Study:

• To systematically identify and characterize breast cancer-specific small noncoding RNAs, termed orphan noncoding RNAs (oncRNAs).
• To investigate the function of a specific oncRNA, T3p, derived from the 3' end of TERC, in breast cancer progression and metastasis.
• To explore the presence and potential role of oncRNAs in extracellular vesicles for cancer pathogenesis and diagnostics.

Main Methods:

• Systematic literature search for breast cancer-specific small noncoding RNAs.
• Functional characterization of identified oncRNAs, focusing on T3p's role in gene expression and metastasis.
• Analysis of oncRNA presence in cancer-cell-derived extracellular vesicles.
• Investigation of T3p's mechanism involving the RISC complex and prometastatic genes (NUPR1, PANX2).

Main Results:

• Identification of a novel class of breast cancer-associated small noncoding RNAs termed oncRNAs.
• Discovery that T3p, an oncRNA from the 3' end of TERC, promotes breast cancer metastasis.
• T3p inhibits RISC complex activity, leading to increased expression of prometastatic genes NUPR1 and PANX2.
• Detection of oncRNAs within cancer-cell-derived extracellular vesicles, suggesting a role in intercellular communication.

Conclusions:

• Orphan noncoding RNAs (oncRNAs) represent a new category of molecules involved in breast cancer.
• The oncRNA T3p is a key driver of breast cancer metastasis through specific gene regulatory mechanisms.
• Circulating oncRNAs in extracellular vesicles offer potential for non-cell autonomous pathogenesis and novel liquid biopsy-based cancer fingerprinting.